Cardiac mechanical dysfunction induced by ischemia-reperfusion in perfused heart isolated from stroke-prone spontaneously hypertensive rats

Clinical and Experimental Hypertension

Volumn 26, Issue 6, 2004, Pages 485-498

  Itoh, Tetsuji ^a   Abe, Kohji ^a   Tokumura, Miwa ^a   Hirono, Satoru ^a   Haruna, Masao ^a   Ibii, Nobuhiro ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Cardioprotective drugs; Hypertension; Hypertrophy; Ischemia reperfusion; Isolated working heart; SHRSP

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL BLOCKING AGENT; CYTOCHROME C OXIDASE; DILAZEP; DILTIAZEM; ISOCITRATE DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTICLE; DRUG EFFECT; ENZYME ASSAY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; ISOLATED HEART; NONHUMAN; RAT; SPECTROPHOTOMETRY; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ADENINE NUCLEOTIDES; ANIMALS; ANTIHYPERTENSIVE AGENTS; CARDIOMEGALY; CEREBROVASCULAR ACCIDENT; DILAZEP; DILTIAZEM; HYPERTENSION; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PERFUSION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REPERFUSION INJURY; VASODILATOR AGENTS; VENTRICULAR PRESSURE;

EID: 7444253373     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-200031822     Document Type: Article

References (37)

1. Levy D. Left ventricular hypertrophy. Epidemiological insights from the Framingham heart study. Drugs 1988; 35(suppl 5):1-5.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322:1561-1566.
3. Gosse P, Clementy J. Coronary reserve in experimental myocardial hypertrophy. Eur Heart J 1995; 16(suppl I):22-25.
4. Koyanagi S, Eastham C, Marcus ML. Effects of chronic hypertension and left ventricular hypertrophy on the incidence of sudden cardiac death after coronary artery occlusion in conscious dogs. Circulation 1982; 65:1192-1197.
5. Koyanagi S, Eastham CL, Harrison DG, Marcus ML. Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy. Circ Res 1982; 50:55-62.
6. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991; 83:1771-1779.
7. 1 adrenergic response. J Clin Invest 1983; 72:732-738.
8. Ito H, Bell D, Tamamori M, Nozato T, Shimojo T, Adachi S, Abe S, Marumo F, Hiroe M. Calcitonin gene-related peptide (CGRP) and hypertrophy of cardiomyocytes. Heart Vessels, Suppl 1997; 12:15-17.
9. Porreca E, Febbo CD, Mincione G, Reale M, Baccante G, Guglielmi MD, Cuccurullo F, Colletta G. Increased transforming growth factor-β production and gene expression by peripheral blood monocytes of hypertensive patients. Hypertension 1997; 30:134-139.
10. Fukuzawa J, Osaki J, Haneda T. Differential effects of amiloride on the basal rate and the pressure overload-induced increase in protein synthesis in perfused rat heart. Clin Exp Hypertens 1994; 16:835-852.
11. Komuro I, Katoh Y, Kaida T, Shibazaki Y, Kurabayashi M, Hoh E, Takaku F, Yazaki Y. Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes. J Biol Chem 1991; 266:1265-1268.
12. Schoemaker RG, Leenen FHH, Harmsen E. Age-related increase in sensitivity for ischemic ATP breakdown in hypertrophic hearts of SHR normalized by enalapril. J Mol Cell Cardiol 1994; 26:649-660.
13. Haneda T, Osaki J, Kikuchi K. Hypertensive cardiac hypertrophy. In: Fujita T, ed. Clinical Science of Hypertension. Osaka: Saishinigaku Co., 1996:253-262.
14. Haneda T, Ichihara K, Abiko Y, Onodera S. Functional and metabolic responses to ischemia in the perfused heart isolated from normotensive and spontaneously hypertensive rats. Jpn Circ J 1986; 50:607-613.
15. Tokoro T, Ito H, Suzuki T. Alterations in mitochondrial DNA and enzyme activities in hypertrophied myocardium of stroke-prone SHRs. Clin Exp Hypertens 1996; 18:595-606.
16. Nasa Y, Ichihara K, Abiko Y. Both d-cis- and 1-cis-diltiazem have anti-ischemic action in the isolated, perfused working rat heart. J Pharmacol Exp Ther 1990; 255:680-689.
17. Bernt E, Bergmeyer HU. Isocitrate dehydrogenase. UV-assay. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. Vol. 2. New York: Academic Press, 1974:624-627.
18. Wharton DC, Tzagoloff A. Cytochrome oxidase from beef heart mitochondria. In: Estabrook RW, Pullman ME, eds. Methods in Enzymology. Vol. 10. New York: Academic Press, 1967:245-250.
19. Oyanagui Y. Reevaluation of assay methods and establishment of kit for Superoxide dismutase activity. Anal Biochem 1984; 142:290-296.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
21. Neely JR, Liebermeister H, Battersby EJ, Morgan HE. Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol 1967; 212:804-814.
22. Chen H, Azuma M, Maeda K, Kajimoto N, Higashino H. Impaired heart function and noradrenaline release after ischemia in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2000; 27:664-670.
23. Chen H, Higashino H, Maeda K, Zhang Z, Ohta Y, Wang Z, Su DF, Yuan WJ. Reduction of cardiac norepinephrine improves postischemic heart function in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 2001; 38:821-832.
24. Tanaka H, Obata H, Haneda T. Effects of regression of left ventricular hypertrophy following atenolol or bunazosin therapy on ischemic cardiac function and myocardial metabolism in spontaneously hypertensive rats. Jpn Circ J 1991; 55:1233-1245.
25. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 1990; 259:H610-H618.
26. Ito H, Hirata Y, Hiroe M, Tsujino M, Adachi S, Takamoto T, Nitta M, Taniguchi K, Marumo F. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 1991; 69:209-215.
27. Shimamoto N, Goto N, Tanabe M, Imamoto T, Fujiwara S, Hirata M. Myocardial energy metabolism in the hypertrophied hearts of spontaneously hypertensive rats. Basic Res Cardiol 1982; 77:359-371.
28. Peyton RB, Jones RN, Attarian D, Sink JD, Trigt PV, Currie WD, Wechsler AS. Depressed high-energy phosphate content in hypertrophied ventricles of animal and man. The biologic basis for increased sensitivity to ischemic injury. Ann Surg 1982; 196:278-284.
29. Yamamoto N, Otsuka Y, Kushiro T, Kajiwara N. Role of Superoxide anion on onset and maintenance of hypertension in spontaneously hypertensive rats. Nippon Jinzo Gakkai Shi 1992; 34:717-723.
30. Rauch U, Schulze K, Witzenbichler B, Schultheiss HP. Alteration of the cytosolic-mitochondrial distribution of high-energy phosphates during global myocardial ischemia may contribute to early contractile failure. Circ Res 1994; 75:760-769.
31. Hugtenburg JG, Mathy M-J, de Haan N, Beckeringh JJ, vanZwieten PA. The influence of calcium antagonists on the adenine nucleotide metabolism in the guinea-pig working heart during ischaemia and reperfusion. Naunyn-Schmiedeberg's Arch Pharmacol 1991; 343:496-504.
32. Schneider A, Zimmer H-G. Effect of inosine on function and adenine nucleotide content of the isolated working rat heart: studies of postischemic reperfusion. J Cardiovasc Pharmacol 1991; 17:466-473.
33. Hugtenburg JG, Mathy M-J, Veldsema-Currie RD, Boddeke HWGM, Beckeringh JJ, van Zwieten PA. A comparison of the cardioprotective effects of calcium antagonists from different classes upon ischaemic damage in the guinea-pig working heart. Naunyn-Schmiedeberg's Arch Pharmacol 1989; 340:126-134.
34. Szekeres L, Udvary E, Vegh A. Importance of myocardial blood flow changes in the protective action of diltiazem in a new model of myocardial ischaemia. Br J Pharmacol 1985; 86:341-350.
35. Hoque ANE, Hoque N, Hashizume H, Abiko Y. A study on dilazep: I. mechanism of anti-ischemic action of dilazep is not coronary vasodilation but decreased cardiac mechanical function in the isolated, working rat heart. Jpn J Pharmacol 1995; 67:225-232.
36. Hamm CW, Opie LH. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart. Circ Res 1983; 52:1129-1138.
37. Lopaschuk GD, Barr R, Wambolt R. Effects of diltiazem on glycolysis and oxidative metabolism in the ischemic and ischemic/reperfused heart. J Pharmacol Exp Ther 1992; 260:1220-1228.